Your Directors take immense pleasure in presenting the Thirtieth (30th) Annual Report covering the highlights of the business, operations and financials of Tatva Chintan Pharma Chem Limited ("the Company") together with the Audited Financial Statements of the Company (standalone and consolidated) prepared in compliance with Indian Accounting Standards (Ind AS), for the financial year ("FY") ended 31 March 2026.
1. Financial Highlights of the Company
|
Particulars
|
Standalone
|
Consolidated
|
|
2025-26
|
2024-25
|
2025-26
|
2024-25
|
|
Revenue from operations
|
4962.96
|
3664.15
|
5058.58
|
3827.14
|
|
Other income
|
35.28
|
35.61
|
35.49
|
23.15
|
|
EBITDA (Including other income)
|
928.58
|
294.05
|
967.07
|
365.28
|
|
EBITDA (Excluding other income)
|
893.30
|
258.44
|
931.58
|
342.13
|
|
Interest and financial charges
|
28.51
|
12.90
|
28.51
|
12.90
|
|
Depreciation and amortisation expense
|
368.42
|
276.54
|
368.47
|
276.59
|
|
Profit / (Loss) before exceptional item and taxes
|
531.65
|
4.61
|
570.09
|
75.79
|
|
Exceptional item
|
-
|
-
|
-
|
-
|
|
Tax expense
|
140.83
|
1.34
|
149.55
|
18.66
|
|
Profit / (Loss) for the year
|
390.82
|
3.27
|
420.54
|
57.13
|
|
Other comprehensive income
|
1.74
|
(2.17)
|
32.20
|
7.07
|
|
Total comprehensive income
|
392.56
|
1.10
|
452.74
|
64.20
|
2. Performance Review and State of Company's Affairs
Consolidated
The Consolidated revenue from operations increased by 32.18% from ' 3827.14 Million for FY 2024-25 to ' 5058.58 Million for FY 2025-26, EBITDA (Including other income)
increased by 164.75% from ' 365.28 Million in FY 2024-25 to ' 967.07 Million in FY 2025-26, Profit after tax increased by 636.11% from ' 57.13 Million in FY 2024-25 to ' 420.54 Million in FY 2025-26. The earnings per shares (Basic / Diluted) increased by 636.89% from ' 2.44 to ' 17.98 as compared to previous financial year.
Standalone
The Standalone revenue from operations increased by 35.45% from ' 3664.15 Million for FY 2024-25 to ' 4962.96 Million for FY 2025-26, EBITDA (Including other income) increased by 215.79% from ' 294.05 Million in FY 2024-25 to ' 928.58 Million in FY 2025-26, Profit after tax increased by 11851.68% from ' 3.27 Million in FY 2024-25 to ' 390.82 Million in FY 2025¬ 26. The earnings per share (Basic / Diluted) have increased by 11,835.71% from ' 0.14 in FY 2024-25 to ' 16.71 in FY 2025-26 as compared to previous financial year. The key elements for profits during the year is cost optimization, prudent internal management, new customer acquisition, new product launch and market growth.
The Export share in "revenue from operations" is 75% during FY 2025-26.
The business has witnessed an improvement in demand across all product categories, reflecting a positive shift in market conditions and customer sentiment. Despite the continued headwinds and uncertainties in the global economic environment, the business remains well positioned and has demonstrated resilience, with demand trends showing encouraging momentum. The Company continues to focus on strengthening its diversified portfolio of innovative products, expanding its customer base, and deepening its presence across new markets, thereby positioning the business for sustainable growth.
3. Innovating the future
The resilience demonstrated by Tatva Chintan during the challenging period has been a defining strength of the Company. Rather than being deterred by the difficult operating environment, the Company used this period to strengthen its infrastructure, optimise capacities and build greater operational efficiency. At the same time, the Company remained steadfast in its focus on R&D, investing in technologies, capabilities and new product development. These investments were made with the clear conviction that challenging times also present an opportunity to prepare for the next phase of growth. Today, as market conditions begin to improve, the value of that preparedness is becoming increasingly evident.
The Company is witnessing a more positive environment across its product categories and businesses, creating opportunities to accelerate its growth journey. Its strengthened infrastructure, optimised capacities and deepening R&D capabilities provide a strong foundation to respond to these opportunities with speed and agility. Innovation at Scale is therefore not merely about developing new products; it is about leveraging the Company's scientific capabilities, manufacturing strengths and market understanding to translate innovation into meaningful commercial opportunities across its businesses.
While global economic uncertainties and headwinds remain, the Company remains confident in its ability to navigate them and deliver healthy, sustainable growth. As it looks ahead, the Company's ambition is to build on the resilience demonstrated in recent years, scale the capabilities it has created and continuously innovate to address evolving customer and market needs. With Innovation at Scale, Powering the Next Decade as its guiding theme, the Company is well positioned to enter its next phase of growth and create enduring value for all its stakeholders.
4. Dividend
Your Company's policy on Dividend Distribution is available athttps://www.tatvachintan.com//webfiles/ CorporateGovernance/PDF/dividend-distribution-policy.pdf
In accordance with the said policy, the Board of Directors has recommended a final dividend of ' 2/- per equity share for the financial year ended 31 March 2026 (previous financial year - ' 1/- per equity shares). If the above recommendation is approved by the Members of the Company at the ensuing Annual General Meeting, the total outflow on this account will be ' 46.78 Million (previous financial year- ' 23.39 Million).
Pursuant to the provisions of the Income-tax Act, 2025, the said final dividend will be liable for deduction of income tax at source.
5. Transfer to Reserves
During the year under review, the Board of Directors has decided to retain the entire amount of profits for FY 2025-26 in the retained earnings and not to transfer any amount to General Reserve.
6. Material Changes and Commitments
The Board of Directors, at its meeting held on 17 July 2026, approved a proposed capacity expansion (addition) project involving an estimated investment of approximately ?200
Crores, to be funded through a combination of internal accruals and debt. As part of our growth strategy, the new manufacturing facility (unit) will further strengthen the Company's infrastructure and help to meet growing market demands.
Other than above, the Company has not made any material changes or commitments which affect the financial position of the Company between the end of the financial year to which the financial statements relate and the date of signing of this report.
7. Share Capital and Change Therein
Authorised Share Capital of the Company is ' 400,000,000/-
(Rupees Forty Crores only) divided into 40,000,000 (Four Crores) Equity Shares of Rs. 10/- (Rupees Ten only) each.
Issued, Subscribed and Paid-up share capital of the Company is Rs. 233,920,550/- (Rupees Twenty Three Crores Thirty Nine Lakhs Twenty Thousand Five Hundred and Fifty only) divided into 23,392,055 (Two Crores Thirty Three Lakhs Ninety Two Thousand and Fifty Five) Equity Shares of Rs. 10/- (Rupees Ten only) each.
a) Buy Back of Securities
Your Company has not bought back any of its securities during the year under review.
b) Sweat Equity
Your Company has not issued any Sweat Equity Shares during the year under review.
c) Bonus Shares
Your Company has not issued any Bonus Shares during the year under review.
d) Employee Stock Option Plan
Your Company has not provided any Stock Option Scheme to the employees.
8. Finance
During the year under review, your Company availed various financial facilities from the existing Bankers as per the business requirements. Your Company has been regular in paying interest and repayment of the principal amount of the lender(s).
9. Change in Nature of Business, if any
During the year under review, there has been no material change(s) in the business of the Company or in the nature of business carried by the Company.
10. Deposits
During the year under review, your Company has not accepted any deposits from public within the meaning of Section 73 of the Companies Act, 2013 ("the Act") read with Companies (Acceptance of Deposits) Rules, 2014. The Company has no unclaimed / unpaid matured deposit or interest due thereon.
14. Directors and Key Managerial Personnel ("KMP") and changes therein Directors
As on 31 March 2026, the Board of Directors of your Company comprised of six Directors, viz., three Executive Directors and three Independent Directors including one Women Independent Director. Details of the same are as below:
|
Sr. No.
|
Name of Director
|
Designation
|
Date of Appointment
|
Date of Cessation
|
|
1
|
Mr. Chintan N. Shah
|
Chairman and Managing Director
|
12/06/1996
|
-
|
|
2
|
Mr. Shekhar R. Somani
|
Whole-time Director
|
12/06/1996
|
-
|
|
3
|
Mr. Ajaykumar M. Patel
|
Whole-time Director
|
12/06/1996
|
-
|
|
4
|
CA Subhash A. Patel
|
Independent Director
|
27/02/2021
|
-
|
|
5
|
Dr. Avani R. Umatt
|
Independent Director
|
27/02/2021
|
-
|
|
6
|
Dr. Manher C. Desai
|
Independent Director
|
27/02/2021
|
-
|
11. Subsidiaries, Joint Ventures and Associate Companies
As on 31 March 2026, your company has Two (2) Wholly Owned Subsidiaries ("WOS") as detailed below;
|
Sr.
No.
|
Name of the Company
|
Type of Company
|
Location
|
|
1.
|
Tatva Chintan
|
Wholly Owned
|
United States of
|
| |
USA Inc.
|
Subsidiary
|
America
|
|
2.
|
Tatva Chintan
|
Wholly Owned
|
Amsterdam,
|
| |
Europe B.V.
|
Subsidiary
|
The Netherlands
|
Statement containing salient features of the financial statement of subsidiaries Company as per the Companies Act, 2013 is provided in form AOC-1 at Annexure-A to this Report.
Your Company's policy on material subsidiary is also available on the website of the Company athttps://www.tatvachintan. com//webfiles/CorporateGovernance/PDF/policy-for- determining-material-subsidiaries.pdf.
Details of New Subsidiary / Joint Ventures / Associate Companies:
There is no new Subsidiary / Joint Ventures / Associate Companies of the Company during the year under review.
Details of the Company who ceased to be its Subsidiary / Joint Ventures / Associate Companies:
No Company ceased to be Subsidiary / Joint Venture / Associate Company of the Company during the year under review.
12. Particulars of Related Party Transactions
In line with the requirements of the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"), as amended from time to time, the Company has formulated a Policy on Related Party Transactions ("RPT Policy") for identifying, reviewing, approving and monitoring of Related Party Transactions. The RPT Policy is available on the Company's website athttps:// www.tatvachintan.com//webfiles/CorporateGovernance/PDF/ policv-on-related-partv-transactions.pdf.
All related party transactions entered into during FY 2025-26 were on arm's length basis and in the ordinary course of business and were reviewed and approved by the Audit Committee. With a view to ensure continuity of day- to-day operations, an omnibus approval is also obtained for related party transactions which are of repetitive in nature and entered in the ordinary course of business and on an arm's length basis. There was no materially significant Related Party Transaction made by the Company during the year that would have required Shareholder's approval under the SEBI Listing Regulations. A statement giving details of all related party transactions entered pursuant to the omnibus approval so granted is placed before the Audit Committee on a quarterly basis for its review.
Pursuant to Section 134(3)(h) of the Companies Act, 2013 read with Rule 8(2) of the Companies (Accounts) Rules, 2014, the details of Related party transaction which were transacted during the year under review on arm's length basis and in the ordinary course of business are set out as in form AOC-2 at Annexure-B to this Report.
In terms of Regulation 23 of the SEBI Listing Regulations, your Company submits details of related party transactions on a consolidated basis as per the format specified in the relevant accounting standards to the stock exchanges on a half-yearly basis.
The details of the transactions with related parties are provided in the accompanying financial statements.
13. Risk Management
Risk Management at Tatva Chintan Pharma Chem Limited forms an integral part of Management focus.
The Risk Management Policy of the Company, which is reviewed by the Risk Management Committee of the Board ("RMC") and approved by the Board of Directors, provides the framework of Enterprise Risk Management ("ERM") by describing mechanisms for the proactive identification and prioritisation of risks based on the scanning of the external environment and continuous monitoring of internal risk factors. The ERM framework identifies, evaluates, manages and reports risks arising from the Company's operations and exogenous factors.
The Company has deployed holistic approaches to drive organization wide Risk Management. The holistic process includes identification and regular assessment of risks by the respective departments and implementation of mitigation strategies.
The RMC oversees the risk management process in the Company. The RMC is chaired by a Whole-time Director and the Chairperson of the Audit Committee is also a Member of the RMC.
Further, the Chairman of the RMC briefs the Board in Board Meetings about the significant discussions at each of the RMC Meeting. This robust governance structure has also helped in the integration of the ERM with the Company's Strategic Planning Process where emerging risks are used as inputs in such process. The RMC meets periodically to review all the key risks, mitigation measures and also assess the status of mitigation measures.
The Risk Management Policy is available on Company's website athttps://www.tatvachintan.com//webfiles/ CorporateGovernance/PDF/risk-management-policy.pdf.
Some of the risks identified are set out in the Management Discussion and Analysis which forms part of this Annual Report.
Risk Management Committee
Pursuant to the provisions of Regulation 21 of the SEBI Listing Regulations, the Board of Directors at their meeting held on 17 January 2022 has constituted a Risk Management Committee which is responsible for management of risk, avoid / reduce exposure to significant financial loss and achieve risk management objectives as specified under Risk Management Policy. The Corporate Governance Report, which forms part of this report, contains the details of Risk Management Committee of the Company.
Director liable to Retire by Rotation
In accordance with the provisions of Companies Act, 2013 and Articles of Association of the Company, Mr. Shekhar R. Somani (DIN: 00183665) is liable to retire by rotation at the ensuing Annual General Meeting of the Company and being eligible, offer himself for re-appointment. The Board recommends the appointment of Mr. Shekhar R. Somani as Director of the Company retiring by rotation for your approval.
Re-appointment(s)
Pursuant to the provisions of the Companies Act, 2013, the term of appointment of Mr. Chintan Nitinkumar Shah (DIN: 00183618), as Managing Director, Mr. Ajaykumar Mansukhlal Patel (DIN: 00183745), as Whole-time Director and Mr. Shekhar Rasiklal Somani (DIN: 00183665), as Whole¬ time Director of the Company shall come to an end on 31 January 2027. On the recommendation of the Nomination and Remuneration Committee ("NRC") and the Board of Directors, the proposal for re-appointment of Mr. Chintan Nitinkumar Shah (DIN: 00183618), as Managing Director, Mr. Ajaykumar Mansukhlal Patel (DIN: 00183745), as Whole-time Director and Mr. Shekhar Rasiklal Somani (DIN: 00183665), as Whole¬ time Director of the Company for a further period of three (3) years from 01 February 2027 to 31 January 2030 (both days inclusive), is being included in the Notice of the ensuing 30th Annual General Meeting for approval of the Members.
Details of the proposal for the appointment / re-appointment of Directors along with their shareholding in the Company, as stipulated under Secretarial Standard 2 of the Institute of Company Secretaries of India and Regulation 36 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, is mentioned in the Notice of the Annual General Meeting.
Cessation
There were no cessations of the Directors during the Financial Year 2025-26.
All the Directors of the Company have confirmed that they are not disqualified from being appointed as Directors in terms of Section 164 of the Companies Act, 2013.
Independent Directors
Your Company has received declarations from all the Independent Directors confirming that they meet the criteria of independence as prescribed under Section 149(6) of the Act read with sub rule (1) and sub rule (2) of Rule 6 of the Companies (Appointment and Qualification of Directors) Rules, 2014 and Regulation 16(1)(b) of the SEBI Listing Regulations and they are independent of the management and they have complied with the code for Independent prescribed in Schedule IV of the Act.
In terms of Regulation 25(8) of the SEBI Listing Regulations, they have confirmed that they are not aware of any circumstance or situation, which exist or may be reasonably anticipated, that could impair or impact their ability to discharge their duties with an objective independent judgement and without any external influence. The Board of Directors of the Company has taken on record the declaration and confirmation submitted by the Independent Directors after undertaking due assessment of the veracity of the same. They are not liable to retire by rotation in terms of Section 149(13) of the Act.
The Board is of the opinion that the all Directors including the Independent Directors of the Company possess requisite qualifications, experience and expertise in their relative fields like science and technology, strategy, finance, governance, human resources, safety, sustainability, etc. and that they hold highest standards of integrity.
The Independent Directors of the Company have confirmed that they have enrolled themselves in the Independent Directors' Databank maintained with the Indian Institute of Corporate Affairs ("IICA") in terms of Section 150 of the Act read with Rule 6 of the Companies (Appointment and Qualification of Directors) Rules, 2014.
Key Managerial Personnel
As on 31 March 2026, the following persons have been designated as Key Managerial Personnel of the Company pursuant to Section 2(51) read with Section 203 of the Act, read with the Rules framed thereunder.
|
Sr. No.
|
Name of Director / KMP
|
Designation
|
Date of Appointment
|
Date of Cessation
|
|
1
|
Mr. Chintan N. Shah
|
Chairman and Managing Director
|
12/06/1996
|
-
|
|
2
|
Mr. Shekhar R. Somani
|
Whole-time Director
|
12/06/1996
|
-
|
|
3
|
Mr. Ajaykumar M. Patel
|
Whole-time Director
|
12/06/1996
|
-
|
|
4
|
Mr. Ashok Bothra
|
Chief Financial Officer
|
03/12/2021
|
30/08/2025
|
|
5
|
Mr. Ajesh Pillai
|
Chief Financial Officer
|
31/10/2025
|
|
|
6
|
Mr. Ishwar Nayi
|
Company Secretary and Compliance Officer
|
17/01/2022
|
-
|
Changes in KMP
During the year under review, Mr. Ashok Bothra resigned and ceased to hold the position of Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) of the Company with effect from the close of business hours on 30 August 2025. The Board places on record its appreciation for his valuable contributions during his tenure.
Appointment of KMP
The Board of Directors, based on the recommendation of Nomination and Remuneration Committee and Audit Committee at its meeting held on 31 October 2025, approved the appointment of Mr. Ajesh Pillai as the Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) of the Company with effect from 31 October 2025.
Your Company has also received declaration from all the Directors and senior management personnel on compliance of Code of Conduct for Directors and senior management personnel, formulated by the Company.
15. Board and Committee Meetings
Details of Board Meetings
During the year under review, four (4) Meetings of the Board of Directors were held in accordance with the provisions of the Companies Act, 2013 read with rules made there under and the applicable secretarial standards. The details of the Board Meetings with regard to their dates and attendance of each of the Directors thereat have been provided in the Corporate Governance Report which forms part of the Annual Report of the Company.
Details of Committee Meetings
The Company has duly constituted the following mandatory Committees in terms of the provisions of the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time viz.
a. Audit Committee;
b. Nomination and Remuneration Committee;
c. Stakeholders Relationship Committee;
d. Risk Management Committee; and
e. Corporate Social Responsibility Committee;
The Composition of all such Committees, number of meetings held during the year under review, attendance of each of the Directors at such meetings, brief terms of reference and other details have been provided in the Corporate Governance Report which forms part of this Annual Report. All the recommendations made by the Committees were accepted by the Board.
16. Separate Meeting of Independent Directors
During the year under review, one (1) Separate meeting of Independent Directors was held on 21 January 2026. The details of the Independent Directors Meeting and the attendance of the Directors are provided in the Corporate Governance Report, which forms part of this Report.
17. Familiarisation Programme
In compliance with the requirements of Regulation 25(7) of the SEBI Listing Regulations, the Company has put in place a Familiarisation Programme for the Independent Directors to familiarise them with the Company, their roles, rights, responsibilities in the Company, nature of the industry in which the Company operates, business model etc. The details of the Familiarisation Programme imparted to Independent Directors are available on the Company's official website athttps:// www.tatvachintan.com//webfiles/CorporateGovernance/ PDF/details-of-familiarization-programme-for-independent- directors.pdf.
18. Evaluation of the Performance of the Board of Directors, its Committees and of Individual Directors
Pursuant to the provisions of the Companies Act, 2013 and SEBI Listing Regulations, as amended, the Board has carried out the annual performance evaluation of its own performance, the Directors individually as well as the evaluation of its committees and Chairperson of the Company. The manner in which the evaluation has been carried out has been explained in the Corporate Governance Report.
19. Directors' Responsibility Statement
Pursuant to Section 134(3)(c) and 134(5) of the Companies Act, 2013, in relation to financial statements of the Company for the year ended 31 March 2026, the Board of Directors to the best of their knowledge and ability, confirm that:
1. In the preparation of the annual accounts, the applicable
accounting standards have been followed and that there are no material departures;
2. The Directors had selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent, so as to give a true and fair view of the state of affairs of the Company at the end of the financial year 31 March 2026 and of the profit of the Company for that period;
3. The Directors had taken proper and sufficient care for maintenance of adequate accounting records in accordance with the provisions of the Companies Act, 2013 for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities;
4. The Directors had prepared the annual accounts on a going concern basis;
5. The Directors laid down the internal financial controls to be followed by the Company and that such internal financial controls are adequate and are operating effectively; and
6. The Directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.
20. I nternal Financial Controls Systems and their Adequacy
Internal Financial Controls are an integrated part of the risk management process. Your Company has adequate internal financial controls in place to address financial and financial reporting risks. The internal financial controls with reference to the financial statements are commensurate with the size, scale and complexity of its operations. The Audit Committee defines the scope and authority of the Internal Auditor. The Audit Committee, comprises of professionally qualified Directors, who interact with the statutory auditors, internal auditors and management in dealing with matters within its terms of reference. Your Company has a proper and adequate system of internal controls. Adequate internal financial controls ensure transactions are authorized, recorded and reported correctly and assets are safeguarded and protected against loss from unauthorized use or disposition.
21. Vigil Mechanism / Whistle Blower Policy
As per provisions of Section 177(9) of the Companies Act, 2013 read with Regulation 22(1) of SEBI Listing Regulations, your Company has adopted a Whistle Blower Policy, to provide a formal vigil mechanism to the Directors and employees to report their grievances / concerns about instances of unethical behavior, actual or suspected fraud or violation of Company's Code of Conduct. The Policy provides for adequate safeguards against victimisation of employees who avail of the mechanism and also provides for direct access to the Chairman of the Audit Committee in certain cases. It is affirmed that no personnel of your Company have been denied access to the Audit Committee. The functioning of the vigil mechanism is reviewed by the Audit Committee from time to time.
The details of the policy as well as its weblink are contained in the Corporate Governance Report and website of the Company athttps://www.tatvachintan.com//webfiles/ CorporateGovernance/PDF/vigil-mechanism-and-whistle- blower-policy.pdf.
22. Significant and Material Orders Passed by the Regulators
During the year under review, no significant and material orders were passed by the regulators or courts or tribunals impacting the going concern status and future operation of the Company
23. Corporate Social Responsibility
In compliance with the requirements of Section 135 of the Act read with the Companies (Corporate Social Responsibility Policy) Rules, 2014, the Board of Directors have constituted a Corporate Social Responsibility ("CSR") Committee. The details of membership of the Committee and the meetings held are detailed in the Corporate Governance Report, forming part of this Report.
CSR Policy is in line with the requirements of the Companies (Corporate Social Responsibility Policy) Amendment Rules, 2021. The CSR Policy of the Company is available on the website of the Company and can be accessed through the website of the Company athttps://www.tatvachintan.com// webfiles/CorporateGovernance/PDF/csr-policv.pdf.
The annual report on CSR activities containing details of expenditure incurred by the Company and brief details on the CSR activities are provided in Annexure-C to this Report.
24. Board Diversity
The Company recognizes and embraces the importance of a diverse Board in its success. Your Company believes that a truly diverse Board will leverage differences in thought, perspective, knowledge, skill, regional and industry experience, cultural and geographical background, age, ethnicity, race and gender, which will help the Company to retain its competitive advantage. The Board has adopted the Board Diversity Policy which sets out the approach to diversity of the Board of Directors. The policy is available on our website athttps:// www.tatvachintan.com/webfiles/CorporateGovernance/PDF/ board-diversity-policy.pdf.
25. Appointment and Remuneration Policy
Your Company has been following a policy with respect to appointment and remuneration of Directors, Key Managerial Personnel and Senior Management Personnel ("SMP"). The appointment of Directors on the Board is subject to the recommendation of the Nomination and Remuneration Committee ("NRC"). Based on the recommendation of the NRC, the remuneration of Executive Director is fixed in accordance with the provisions of the Companies Act, 2013 which comprises of Basic Salary and Perquisites / Allowances. The Remuneration of Non-Executive Directors comprises of
sitting fees in accordance with the provisions of Companies Act, 2013. The Company had adopted a Remuneration Policy for the Directors, Key Managerial Persons and other employees, pursuant to the provisions of the Act. Managing Director of the Company does not receives any remuneration or commission from any of its subsidiaries. The Remuneration Policy is stated in the Corporate Governance report and weblink for the same ishttps://www.tatvachintan.com/webfiles/ CorporateGovernance/PDF/nomination-and-remuneration- policv.pdf.
26. Particulars of Employees
Details of remuneration of Directors, KMPs and employees as per Section 197 of the Companies Act, 2013 read with Rule 5(1) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, forms part of Report as Annexure-D. However, as per the provisions of Section 136 of the Companies Act, 2013, the Annual Report is being sent to the Members and others entitled thereto, excluding the information on employees' remuneration particulars as required under Rule 5 (2) and (3) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014. The disclosure is available for inspection by the Members at the Registered Office of your Company during business hours on all working days of the Company up to the date of the ensuing AGM. Any Member interested in obtaining such information may send their email to cs@tatvachintan.com.
27. Auditors and Their Report
i. Statutory Auditors
At the 27th AGM held on 22 September 2023, M/s. NDJ & Co., Chartered Accountants, (Firm Registration No. 136345W) ("NDJ & Co.") were appointed as Statutory Auditors of the Company for a second term of five (5) consecutive years and shall hold office till the conclusion of 32nd Annual General Meeting of the Company.
The auditors' Report does not contain any qualification, observation, disclaimer, reservation or adverse remark.
ii. Cost Auditors and Maintenance of Cost Records
Pursuant to Section 148 of the Companies Act, 2013 read with the Companies (Cost Records and Audit) Rules, 2014, Your Company is required to prepare, maintain as well as have the audit of its cost records conducted by a Cost Accountant in whole time practice and accordingly, it has made and maintained such cost accounts and records.
The Board, on the recommendation of the Audit Committee has appointed M/s. Zarna Thakar & Associates, Cost Accountants (FRN: 005956), Vadodara to carry out Cost Audit and issue Cost Audit Report for the Financial Year 2026-27 at a professional fee of ' 1,05,000/- (Rupees One Lakh Five Thousand only) plus
applicable taxes and out of pocket expenses on actual basis, if any.
M/s. Zarna Thakar & Associates have confirmed that they are free from disqualification specified under Section 141(3) and proviso to Section 148(3) read with Section 141(4) of the Act and that the appointment meets the requirements of the Act. They have further confirmed their independent status and an arm's length relationship with the Company.
The remuneration payable to the Cost Auditors is required to be placed before the Members in a General Meeting for their ratification. Accordingly, a resolution seeking Members' ratification for the remuneration payable to M/s. Zarna Thakar & Associates, forms part of the Notice of the 30th AGM forming part of this Annual Report.
The Cost Audit Report for the year under review issued by M/s. Zarna Thakar & Associates, Cost Accountants, does not contain any qualification, reservation or adverse remark or disclaimer.
iii. Secretarial Auditors
At the 29th AGM held on 26 September 2025, M/s. TNT & Associates, Practicing Company Secretaries were appointed as Secretarial Auditors of the Company to carry out Secretarial Audit for five (5) consecutive years commencing from FY 2025-26 till FY 2029-30.
The report of the Secretarial Auditors for FY 2025-26 is enclosed as Annexure-E forming part of this Report.
There has been no qualification, reservation, adverse remark or disclaimer given by the Secretarial Auditors in their Report.
In accordance with the SEBI Circular dated 08 February 2019 read with Regulation 24A of the SEBI Listing Regulations, the Company has obtained an Annual Secretarial Compliance Report from M/s. TNT & Associates, Practicing Company Secretaries, Vadodara, confirming compliances with all applicable SEBI Listing Regulations, Circulars and Guidelines for the financial year 2025-26. The Annual Secretarial Compliance Report for abovesaid financial year has been submitted to the stock exchanges within 60 days of the end of the said financial year.
M/s. TNT & Associates, Practicing Company Secretaries, Vadodara, has issued a certificate confirming that none of the Directors on the Board of the Company has been debarred or disqualified from being appointed or continuing as Directors of companies by Securities and Exchange Board of India ("SEBI") / Ministry of Corporate Affairs ("MCA") or any such statutory authority. The said Certificate is annexed to this Report on Corporate Governance.
28. Credit Ratings
During the financial year under review, the long term and short term credit ratings of your Company has been revised from "A-/Negative and A2 " to "BBB /Stable and A2" respectively.
29. Consolidated Financial Statements
The Consolidated Financial Statements of the Company and its subsidiaries for FY 2025-26 are prepared in compliance with the applicable provisions of the Act and as stipulated under Regulation 33 of the SEBI Listing Regulations as well as in accordance with the Indian Accounting Standards notified under the Companies (Indian Accounting Standards) Rules, 2015. The Audited Consolidated Financial Statements together with the Auditor's Report thereon forms part of this Annual Report.
30. Agreements - Green Energy (Hybrid Project - Wind and Solar)
In February 2026, the Company had entered into a Power Purchase Agreement with AMPIN C&I Power Twenty Six Private Limited (SPV); and a Share Purchase, Subscription and Shareholder's Agreement, along with an Option Agreement, with AMPIN C&I Power Private Limited and AMPIN C&I Power Twenty Six Private Limited. These Agreements, entered into under the Group Captive Power Scheme, would enable the Company to source environment friendly Green Energy from this 3.2 MW Wind-Solar hybrid project for captive consumption on a long-term basis and would help in reducing the energy costs of the Company significantly in the years to come. It will also reduce reliance on non-renewable source of energy.
In accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has filed the necessary intimation regarding this equity share acquisition with the Stock Exchanges.
31. Information Regarding Conservation of Energy, Technology Absorption, Foreign Exchange Earnings and Outgo
The information relating to conservation of energy, technology absorption and foreign exchange earnings and outgo as stipulated under Section 134(3)(m) of the Companies Act, 2013 read with the Companies (Accounts) Rules, 2014 is set out herewith as Annexure-F forming part of this report.
32. Corporate Governance Report
Your Company believes in conducting its affairs in a fair, transparent and professional manner along with good ethical standards, transparency and accountability in its dealings with all its constituents. Your Company has Complied with all the Mandatory Requirements of Corporate Governance norms as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.
The Separate report on Corporate Governance as well as the Secretarial Auditor's certificate on the compliance of
Corporate Governance thereon forms part of this report as Annexure-G.
33. Details of loans availed from Directors or their relatives
During the year under review, your Company has not availed any loan(s) from the Directors or their Relatives.
34. Failure to Implement any Corporate Action
During the year under review, no such instance where the Company has failed to complete or implement any corporate action within specified time limit.
35. Business Responsibility and Sustainability Report
Pursuant to Regulation 34(2)(f) of the SEBI Listing Regulations, the Business Responsibility and Sustainability Report ("BRSR") of your Company for FY 2025-26 is forming part of this Annual Report as Annexure-H describing the initiatives taken by the Company from an environmental, social and governance perspective.
36. Management's Discussion and Analysis Report
Management Discussion and Analysis as required under Schedule V of the SEBI Listing Regulations is forming part of this Annual Report as Annexure-I.
37. Particulars of Loans Given, Guarantees Given, Security Provided or Investments made under Section 186 of Companies Act, 2013
Details of Loans, Guarantees and Investments covered under the provisions of Section 186 of the Companies Act, 2013 are given in the notes forming part of the Financial Statements and forms a part of this Annual Report.
38. Disclosure under the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013
Your Company is fully committed to uphold and maintain the dignity of every woman working with the Company. Your Company has Zero tolerance towards any action on the part of any one which may fall under the ambit of 'Sexual Harassment at workplace'.
Pursuant to the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 ("POSH Act") and Rules made thereunder, the Company has formed an Internal Complaint Committee ("ICC") for its workplaces to address complaints pertaining to sexual harassment in accordance with the POSH Act. The Company has a detailed policy for prevention of sexual harassment at workplace which ensures a free and fair enquiry process with clear timelines for resolution.
The Policy is uploaded on the website of the Company athttps:// www.tatvachintan.com/webfiles/CorporateGovernance/PDF/
policy-on-prevention-and-resolution-of-sexual-harassment-at-
workplace.pdf.
The details of complaints filed, disposed of and pending are given below:
(a) Number of complaints of sexual harassment received in the financial year 2025-26- Nil
(b) Number of complaints disposed of during the financial year 2025-26- Nil
(c) Number of cases pending for more than ninety days- Nil
(d) Number of complaints pending as on end of the financial year 2025-26- Nil
Further details have been provided in Corporate Governance Report forming part of this report.
39. Compliance of the provisions relating to the Maternity Benefit Act, 1961
During the year under review, your Company has complied with all the applicable provisions relating to the Maternity Benefit Act, 1961 as may be amended from time to time. Your Company remains committed to creating an inclusive and supportive environment for women, especially during and after pregnancy, to ensure their health, dignity, and continued career growth.
40. Annual Return
Pursuant to Section 92(3) read with Section 134(3)(a) of the Companies Act read with the Rules made thereunder, the Annual Return in form MGT-7 as on 31 March 2026 is available on the Company's website athttps://www. tatvachintan.com//webfiles/FinancialInformation/ PDF/16512026105151Annual%20Return%20(MGT-7).pdf.
41. Insurance
The Company takes a very cautious approach towards insurance. Adequate cover has been taken for all stock and fixed assets for various types of risks. The Company has Directors and Officers Liability Insurance Policy to provide coverage against the liabilities arising on them.
42. Secretarial Standard
During the year under review, your Company has complied with all the applicable Secretarial Standards issued by the Institute of Company Secretaries of India ("ICSI").
43. Investor Education and Protection Fund ("IEPF")
During the year under review, no amount is required to transferred to Investors Education and Protection Fund.
Your Company has appointed Mr. Ishwar Nayi, Company Secretary and Compliance Officer of the Company as Nodal Officer of the Company. Details of the same is available on the
websites of the Company athttps://www.tatvachintan.com/ investors-contacts.aspx.
44. Proceedings Pending under the Insolvency and Bankruptcy Code ("IBC")
There is no such proceeding or appeal pending under Insolvency and Bankruptcy Code, 2016 (31 of 2016) during the year and at the end of the financial year, even upto the date of this report.
45. The details of difference between Amount of the valuation done at the time of one time settlement and the Valuation done while taking loan from the Banks or Financial Institutions
No such instance of One-time settlement or valuation was done while taking or discharging loan from the Banks / Financial institutions occurred during the year.
46. Reporting of Fraud During the year under review
The Auditors have not reported any instances of frauds committed in your Company by its officers or employees, to the Audit Committee under Section 143(12) of the Act details of which needs to be mentioned in this Report.
47. Revision in Financial Statement or Boards Report
During the year under review, no revision in Financial Statement or Boards Report has been made.
48. Events Subsequent to the date of Financial Statements
As on the date of this Report, your Directors are not aware of any circumstances not otherwise dealt with in this Report or in the financial statements of your Company, which would render any amount stated in the Accounts of the Company misleading. In the opinion of the Directors, no item, transaction or event of a material and unusual nature has arisen in the interval between the end of the financial year and the date of this report, which would affect substantially the results, or the operations of your Company for the financial year in respect of which this report is made.
49. Industrial Relations / Personnel
Your Company is committed to uphold its excellent reputation in the field of Industrial relations. Through continuous efforts, the Company invests and improvises development programmes for its employees.
50. Cautionary Statement
Statements in the Annual Report, including those which relate to Management Discussion and Analysis describing the Company's objectives, projections, estimates and expectations, may constitute 'forward looking' statements within the meaning of applicable laws and regulations. Although the expectations are based on reasonable assumptions, the actual results might differ.
51. Acknowledgement
The Board of Directors places on record their grateful appreciation for the assistance and continued support received from various Central and State Government Departments, Organizations and Agencies involved therein. Your Directors also gratefully acknowledge all stakeholders of the Company viz. Customers, Members, Dealers, Vendors, Banks and other business partners for the excellent support received from them during the year under review. The Directors place on record their sincere appreciation to all employees of the Company for their unstinted commitment and continued contribution to achieve goals of the Company.
On behalf of the Board of Directors Chintan N. Shah
Date: 17 July 2026 Chairman and Managing Director
Place: Vadodara DIN: 00183618
|